Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 - Research and Markets

Research and Markets
Posted on: 24 Aug 17

The "Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2017" report has been added to Research and Markets' offering.

The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors product or technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all discovery stage partnering deals announced since 2010 including financial terms where available including over 3,000 links to online deal records of actual discovery partnering deals as disclosed by the deal parties.

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 include:

  • Trends in discovery stage dealmaking in the biopharma industry since 2010
  • Analysis of discovery stage deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life discovery stage deals
  • Access to over 3,000 discovery stage deals
  • The leading discovery stage deals by value since 2010
  • Most active discovery stage dealmakers since 2010
  • The leading discovery stage partnering 2010

The available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal type
  • Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Why do companies partner at discovery stage?

Chapter 3 - Discovery stage deal strategies and structure

Chapter 4 - Discovery stage partnering payment strategies

Chapter 5 - Trends in discovery stage deal making

Chapter 6 - Payment terms for discovery stage partnering

Chapter 7 - Leading discovery stage deals

Chapter 8 - Top 50 most active discovery stage dealmakers

Chapter 9 - Discovery stage partnering contracts directory

Chapter 10 - Discovery stage deal making by development stage

For more information about this report visit

View source version on

Business Wire

Last updated on: 24/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.